TRAVERE THERAPEUTICS TVTX 深 沪
已收盘 09-06 16:00:00 美东时间
10.98
+1.050
+10.57%
华盛通- 最 高11.91
- 今 开10.80
- 成交量 789.36万股
- 最 低 10.64
- 昨 收 9.93
- 总市值 8.24亿
- 52周最高 14.62
- 市盈率 静 --
- 换手率 10.52%
- 52周最低 5.12
- 委 比 21.27%
- 总股本 7501.09万
- 历史最高 37.04
- 量 比 6.16
- 振 幅 12.79%
- 历史最低 0.90
- 每 手 1
- 风险率 1.75%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Travere(TVTX.US)“first-in-class”疗法获FDA完全批准 显著减缓肾功能下降
9月7日，Travere Therapeutics(TVTX.US)宣布，美国FDA完全批准“first-in-class”疗法Filspari(sparsentan)。
09-07 15:37
Citigroup Maintains Buy on Travere Therapeutics, Raises Price Target to $23
Citigroup analyst Carly Kenselaar maintains Travere Therapeutics (NASDAQ:TVTX) with a Buy and raises the price target from $14 to $23.
09-07 02:47
NIO To Rally Around 65%? Here Are 10 Top Analyst Forecasts For Friday
Top Wall Street analysts changed their outlook on these top names. For a comple...
09-06 20:16
Positive Outlook for Travere Therapeutics with Sparsentan’s Endorsement and Anticipated FDA Approval
Travere Therapeutics (TVTX – Research Report), the Healthcare sector company, w...
08-31 00:55
Novartis gets FDA approval for Fabhalta in IgAN patients
Novartis (NYSE:NVS) has received FDA accelerated approval for its drug Fabhalta to be used in the reduction of proteinuria in adults with primary immunoglobulin A nephropathy, or IgAN, at risk of rapi...
08-08 04:57
Expert Ratings For Travere Therapeutics
4 analysts have expressed a variety of opinions on Travere Therapeutics (NASDAQ...
08-02 22:00
Travere Therapeutics files for mixed shelf offering
Travere Therapeutics (NASDAQ:TVTX) on Thursday said that it filed a prospectus for a mixed shelf offering, with the size undisclosed. The prospectus is not an offer to sell. SEC Filing. More on Traver...
08-02 05:47
Nvidia, Micron, Arlo Technologies And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were mixed, with the Dow Jones index falling around 100 points on T...
07-09 22:05
Travere Therapeutics Shareholders Back Management and Growth Plan
Travere Therapeutics (TVTX) has provided an announcement. During the Annual Mee...
05-14 04:25
Travere Therapeutics shares are trading higher following Q1 earnings.
Travere Therapeutics shares are trading higher following Q1 earnings.
05-07 23:20
